The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of tremelimumab, durvalumab, and bevacizumab in advanced biliary tract cancers.
 
Kelley Lauren Coffman
No Relationships to Disclose
 
Changqing Xie
No Relationships to Disclose
 
Donna M. Hrones
No Relationships to Disclose
 
M. Cecilia Monge B.
No Relationships to Disclose
 
David E. Kleiner
No Relationships to Disclose
 
Seth M. Steinberg
No Relationships to Disclose
 
Bernadette Redd
No Relationships to Disclose
 
Brad J. Wood
Research Funding - Biocompatibles BTG (Inst); Boston Scientific (Inst); Celsion (Inst); Exact Imaging (Inst); Navidea (Inst); Philips Healthcare (Inst); Philips/inVivo (Inst); Profound Medical (Inst); Siemens (Inst); Xact Robotics (Inst)
Patents, Royalties, Other Intellectual Property - Named as inventor on multiple patents, invention reports, and intellectual property (Inst); NIH and Biocompatibles share intellectual property and patents in the field of drug eluting microspheres for tumor embolization (Inst); NIH and Philips have a licensed shared patents and intellectual property, under which I receive royalties
Travel, Accommodations, Expenses - Biocompatibles BTG; Navidea (Inst); Philips Healthcare; Siemens
Other Relationship - Smart City Media; Springer
 
Michael Kassin
No Relationships to Disclose
 
Elliot Levy
No Relationships to Disclose
 
Mohamed-Reda Benmebarek
No Relationships to Disclose
 
Tim F. Greten
No Relationships to Disclose